Preparation for preventing and treating shrimp enterocytozoonosis and preparation method and application thereof

By adding a proportionally mixed preparation of specific essential oils and trace elements to shrimp feed, the prevention and treatment problems of enteroplasmosis in shrimp liver are solved, significantly improving the disease resistance and breeding benefits of shrimp, ensuring safety in use.

CN118948932APending Publication Date: 2024-11-15沈激
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411005513.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

At present, there is a lack of effective prevention and control preparations for shrimp hepatocetes disease, which has led to slow growth, white stool problems and economic losses in the shrimp breeding industry.

Method used

Develop a preparation by combining eucalyptus essential oil, eucommia essential oil, torreya essential oil, APG1214 and vermouth essential oil with ferric citrate, zinc methionate, copper glycine, manganese sulfate, selenium methionate, iodized salt, potassium iodate, magnesium sulfate, wheat Raw materials such as rice stone powder are mixed in a specific proportion to make composite additives and composite trace elements, and added to shrimp feed to prevent and treat shrimp liver enteroplasmosis.

Benefits of technology

It significantly improves the disease resistance of shrimps, reduces breeding risks, improves breeding benefits, and is harmless to the shrimps and is safe and convenient to use.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948932A_ABST
    Figure CN118948932A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation for preventing and treating shrimp enterocytozoonosis and a preparation method and application thereof.The preparation is composed of a composite additive and composite trace elements according to the mass ratio of 10-15: 5-8, and the composite additive is prepared from, by weight, 1-5 parts of eucalyptus essential oil, 1-5 parts of eucommia ulmoides essential oil, 1-5 parts of torreya grandis essential oil, 1-5 parts of APG1214 and 1-5 parts of wormwood essential oil; the compound trace elements are prepared from the following components in parts by weight: 5 to 15 parts of ferric citrate, 20 to 40 parts of zinc methionine, 15 to 35 parts of copper glycinate, 5 to 20 parts of manganese sulfate, 0.015 to 0.05 part of selenium methionine, 0.15 to 0.3 part of iodized salt, 0.015 to 0.05 part of cobalt methionine, 400 to 600 parts of potassium iodate, 15 to 40 parts of magnesium sulfate and 300 to 1000 parts of medical stone powder. The preparation method of the preparation comprises the following steps: 1) weighing the raw materials of the composite additive in parts by weight, and mixing, stirring and dissolving the raw materials to obtain a mixed base solution; (2) weighing the raw materials of the compound trace elements in parts by weight, adding the raw materials into the mixed base solution, uniformly stirring, sealing and packaging, and storing in a shade place; the preparation is used for preventing and treating the shrimp enterocytozoonosis hepatopenaei.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of aquaculture, and in particular to a preparation for preventing and treating shrimp hepatoenteric cytosis, and a preparation method and use thereof. Background Art

[0002] With the rapid development of intensive shrimp farming, the diseases faced by shrimp farming in my country are becoming more and more serious, such as white spot syndrome, infectious subcutaneous and hematopoietic necrosis, Taura syndrome, acute hepatopancreatic necrosis, stealing death disease, etc. In recent years, the newly discovered shrimp hepatocystis (Enterocytozoonhepatopenaei) in shrimp has gradually threatened the healthy development of the shrimp farming industry. The growth of shrimp infected with shrimp hepatocystis slows down, and the size of the shrimp in the affected ponds varies greatly, which seriously affects the shrimp's cultivation cycle, feed return rate and market price, causing great economic losses to the farming industry;

[0003] Enterocytozoon hepatopenaei (EHP) belongs to microsporidia, a single-cell eukaryotic organism that parasitizes cells exclusively. It is about 1 micron in size and mainly parasitizes the hepatopancreatic epithelial cells of shrimp. Its parasitism not only causes the shrimp to grow slowly, but also causes white feces in the shrimp. When testing shrimp in a pond in a certain area, the detection rate of enterocytozoon hepatopenaei in shrimps that are obviously smaller and produce white feces is almost 100%. Therefore, it is inevitable to effectively prevent and control the occurrence and spread of enterocytozoon hepatopenaei.

[0004] Currently, there is no preparation on the market for white feces syndrome caused by EHP infection. Therefore, it is of great significance to develop a new and efficient preparation for the prevention and treatment of shrimp hepatoenteroides disease. Summary of the invention

[0005] The technical problem to be solved by the present invention is to overcome the defects of the above-mentioned technology and provide a preparation for preventing and treating shrimp hepatoenteric cytosis and its preparation method and use.

[0006] In order to solve the above technical problems, the technical solution provided by the present invention is a preparation for preventing and treating shrimp hepatoenteric cytosis, the preparation is composed of a composite additive and a composite trace element in a mass ratio of 10-15:5-8, the composite additive is composed of the following raw materials: eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, wormwood essential oil;

[0007] The composite trace element is composed of the following raw materials: ferric citrate, zinc methionine, copper glycinate, manganese sulfate, selenium methionine, iodized salt, cobalt methionine, potassium iodate, magnesium sulfate and medical stone powder.

[0008] Furthermore, the composite additive comprises, by weight: 1-5 parts of eucalyptus essential oil, 1-5 parts of eucommia essential oil, 1-5 parts of Torreya grandis essential oil, 1-5 parts of APG1214, and 1-5 parts of wormwood essential oil.

[0009] Furthermore, the composite trace elements include, by weight, 5-15 parts of ferric citrate, 20-40 parts of methionine zinc, 15-35 parts of glycinate copper, 5-20 parts of manganese sulfate, 0.015-0.05 parts of methionine selenium, 0.15-0.3 parts of iodized salt, 0.015-0.05 parts of methionine cobalt, 400-600 parts of potassium iodate, 15-40 parts of magnesium sulfate, and 300-1000 parts of medical stone powder.

[0010] The second object of the present invention is to provide a method for preparing the above-mentioned preparation for preventing and treating shrimp hepatoenteric cytosis, comprising the following steps:

[0011] Step 1) Weigh eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, and wormwood essential oil by weight, mix the eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, and wormwood essential oil, then add APG1214, and stir until completely dissolved to obtain a mixed base liquid;

[0012] Step 2) Weigh each raw material of the composite trace elements by weight, then slowly add it to the mixed base liquid, continue stirring until the mixture is evenly mixed, and finally seal it and store it in a cool place for later use.

[0013] The third object of the present invention is to provide the use of the preparation prepared by the above preparation method, wherein: the preparation is used to prevent and treat shrimp hepatoenteric cytosis.

[0014] Furthermore, the preparation is added to shrimp feed for use.

[0015] Furthermore, the preparation is added in an amount of 2-4 grams per kilogram of feed, fed 3-5 times a day, and used continuously for 13-15 days.

[0016] The advantages of the present invention over the prior art are that the preparation of the present invention has a significant effect of preventing and treating shrimp hepatoenteric cytosis, is harmless to the shrimp body, and is safe and convenient to use. By adding it to shrimp feed, the disease resistance of shrimp can be effectively improved, the breeding risk can be reduced, and the breeding efficiency can be improved. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 It is a test result diagram of the survival rate of shrimps in experimental group 1, experimental group 2 and control group in Example 3 of the present invention;

[0018] Figure 2 It is a graph showing the test results of the average body length of the prawns in the experimental group 1, the experimental group 2, and the control group in Example 3 of the present invention;

[0019] Figure 3 This is a graph showing the average body weight of shrimps in experimental group 1, experimental group 2, and control group in Example 3 of the present invention. DETAILED DESCRIPTION

[0020] The following is a further detailed description of a preparation for preventing and treating shrimp hepatoenteric cytosis and its preparation method and use in conjunction with the embodiments of the present invention.

[0021] Example 1

[0022] A preparation for preventing and treating hepatoenteric cytosis of shrimp, the preparation comprising a composite additive and a composite trace element in a mass ratio of 11:6, the composite additive comprising, by weight: 2 parts of eucalyptus essential oil, 2 parts of eucommia essential oil, 3 parts of Torreya grandis essential oil, 2 parts of APG1214, and 2 parts of wormwood essential oil;

[0023] The composite trace elements include, by weight, 7 parts of ferric citrate, 25 parts of zinc methionine, 21 parts of copper glycinate, 8 parts of manganese sulfate, 0.03 parts of selenium methionine, 0.2 parts of iodized salt, 0.03 parts of cobalt methionine, 450 parts of potassium iodate, 21 parts of magnesium sulfate, and 500 parts of medical stone powder;

[0024] The preparation method of the preparation for preventing and treating shrimp hepatoenteric cytosis comprises the following steps:

[0025] Step 1) Weigh eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, and wormwood essential oil by weight, mix the eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, and wormwood essential oil, then add APG1214, and stir until completely dissolved to obtain a mixed base liquid;

[0026] Step 2) Weigh each raw material of the composite trace element by weight, then slowly add it to the mixed base liquid, continue stirring until the mixture is uniform, and finally seal it and store it in a cool place for later use;

[0027] The preparation is used for preventing and treating shrimp hepatoenteric cytosis, and the method of using the preparation is to add the preparation into shrimp feed.

[0028] Example 2

[0029] A preparation for preventing and treating hepatoenteric cytosis of shrimp, the preparation comprising a composite additive and a composite trace element in a mass ratio of 11:6, the composite additive comprising, by weight: 4 parts of eucalyptus essential oil, 3 parts of eucommia essential oil, 4 parts of Torreya grandis essential oil, 4 parts of APG1214, and 4 parts of wormwood essential oil;

[0030] The composite trace elements include, by weight, 12 parts of ferric citrate, 33 parts of zinc methionine, 30 parts of copper glycinate, 18 parts of manganese sulfate, 0.04 parts of selenium methionine, 0.25 parts of iodized salt, 0.04 parts of cobalt methionine, 550 parts of potassium iodate, 35 parts of magnesium sulfate, and 800 parts of medical stone powder;

[0031] The preparation method of the preparation for preventing and treating shrimp hepatoenteric cytosis comprises the following steps:

[0032] Step 1) Weigh eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, and wormwood essential oil by weight, mix the eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, and wormwood essential oil, then add APG1214, and stir until completely dissolved to obtain a mixed base liquid;

[0033] Step 2) Weigh each raw material of the composite trace element by weight, then slowly add it to the mixed base liquid, continue stirring until the mixture is uniform, and finally seal it and store it in a cool place for later use;

[0034] The preparation is used for preventing and treating shrimp hepatoenteric cytosis, and the method of using the preparation is to add the preparation into shrimp feed.

[0035] Example 3

[0036] 1) Experimental Grouping

[0037] 90 diseased shrimps were randomly divided into three groups: experimental group 1, experimental group 2, and control group.

[0038] 2) Experimental process

[0039] Experimental group 1 used the preparation prepared in Example 1 and added it to commercial feed at a rate of 3 g per kg of feed;

[0040] Experimental group 2 used the preparation prepared in Example 2 and added it to commercial feed at a rate of 3 g per kg of feed;

[0041] The control group used commercial feed without adding preparations;

[0042] The number of times feed was fed per day in experimental group 1, experimental group 2, and control group was 3 times;

[0043] 3) Experimental comparison items

[0044] The experimental period was two weeks. After the experiment, the content of hepatoenterozoa in the hepatopancreas of shrimp was detected by fluorescence quantitative PCR.

[0045] At the same time, the data of their survival rate, body length and weight were compared;

[0046] 4) Experimental conclusion

[0047] ① The content of hepatoenteric cytozoa in the hepatopancreas of shrimp in experimental group 1 was not detected; the content of hepatoenteric cytozoa in the hepatopancreas of shrimp in experimental group 2 was not detected; the content of hepatoenteric cytozoa in the hepatopancreas of shrimp in the control group was (4.1±1.7)×10 5 copies / mg;

[0048] ② The survival rate of shrimp in experimental group 1 was 95.47%; the survival rate of shrimp in experimental group 2 was 96.3%; the survival rate of shrimp in the control group was 81.23%. Figure 1 As shown;

[0049] ③ The average body length of shrimp in experimental group 1 was 5.8 cm; the average body length of shrimp in experimental group 2 was 5.7 cm; the average body length of shrimp in the control group was 4.6 cm. Figure 2 As shown;

[0050] ④ The average weight of shrimp in experimental group 1 was 2.3g; the average weight of shrimp in experimental group 2 was 2.35g; the average weight of shrimp in the control group was 1.15g. Figure 3 shown.

[0051] The present invention and its implementation methods are described above, and such description is not restrictive. In short, if ordinary technicians in the field are inspired by it, without departing from the purpose of the invention, they can design structures and embodiments similar to the technical solution without creativity, which should all fall within the protection scope of the present invention.

Claims

1. A preparation for preventing and treating shrimp hepatoenteric cytosis, characterized in that: The preparation is composed of a composite additive and a composite trace element in a mass ratio of 10-15:5-8, and the composite additive is composed of the following raw materials: eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, and wormwood essential oil; The composite trace element is composed of the following raw materials: ferric citrate, zinc methionine, copper glycinate, manganese sulfate, selenium methionine, iodized salt, cobalt methionine, potassium iodate, magnesium sulfate and medical stone powder.

2. The preparation for preventing and treating shrimp hepatoenteric cytosis according to claim 1, characterized in that: The composite additive comprises, by weight, 1-5 parts of eucalyptus essential oil, 1-5 parts of eucommia essential oil, 1-5 parts of torreya grandis essential oil, 1-5 parts of APG1214 and 1-5 parts of wormwood essential oil.

3. The preparation for preventing and treating shrimp hepatoenteric cytosis according to claim 1, characterized in that: The composite trace elements include, by weight, 5-15 parts of ferric citrate, 20-40 parts of methionine zinc, 15-35 parts of glycinate copper, 5-20 parts of manganese sulfate, 0.015-0.05 parts of methionine selenium, 0.15-0.3 parts of iodized salt, 0.015-0.05 parts of methionine cobalt, 400-600 parts of potassium iodate, 15-40 parts of magnesium sulfate and 300-1000 parts of medical stone powder.

4. A method for preparing a preparation for preventing and treating shrimp hepatoenteric cytosis according to any one of claims 1 to 3, characterized in that: The following steps are involved: Step 1) Weigh eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, APG1214, and wormwood essential oil by weight, mix the eucalyptus essential oil, eucommia essential oil, Torreya grandis essential oil, and wormwood essential oil, then add APG1214, and stir until completely dissolved to obtain a mixed base liquid; Step 2) Weigh each raw material of the composite trace elements by weight, then slowly add it to the mixed base liquid, continue stirring until the mixture is evenly mixed, and finally seal and package it, store it in a cool place for later use.

5. Use of the preparation prepared by the preparation method according to claim 4, characterized in that: The preparation is used for preventing and treating shrimp hepatoenteric cytosis.

6. The use of the preparation according to claim 5, characterized in that The preparation is added into shrimp feed for use.

7. The use of the preparation according to claim 6, characterized in that The preparation is added in an amount of 2-4 grams per kilogram of feed, fed 3-5 times a day, and used continuously for 13-15 days.

Citation Information

Cited By

  • Feed additive for preventing and treating shrimp sporidiosis and preparation method thereof

    CN121153798A